STRO Kronos AI forecast
A 30-trading-day price forecast for Sutro Biopharma Inc. (STRO) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Sutro Biopharma Inc. at $23.37 on 2026-12-08, +163.5% from the last close of $8.87 on 2026-10-27. Eight out of ten sampled paths end between $19.04 and $29.40, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of STRO
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $7.83 | $6.52 | $9.91 |
| 2026-11-10 | $11.60 | $8.97 | $12.59 |
| 2026-11-17 | $15.11 | $13.09 | $19.22 |
| 2026-11-24 | $17.57 | $15.19 | $23.45 |
| 2026-12-01 | $20.88 | $17.85 | $24.25 |
| 2026-12-08 | $23.37 | $19.04 | $29.40 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for STRO?
- Kronos AI's median forecast for STRO is $23.37 in 30 trading days, +163.5% from the last close, with a 10–90% range of $19.04 to $29.40.
- Is the STRO Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- AMGN — Amgen Inc.
- GILD — Gilead Sciences Inc.
- MRNA — Moderna Inc.
- ARGX — argenx SE American Depositary Shares
- RVMD — Revolution Medicines Inc.
- BIIB — Biogen Inc.